Molecular

HPV Molecular

Transcription-MediatedAmplification (TMA) by HOLOGIC-Aptima HPV assay, for the qualitative detectionof E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of humanpapillomavirus (HPV) in cervical specimens. The high-risk HPV types detected bythe assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.

Full Description

Transcription-MediatedAmplification (TMA) by HOLOGIC-Aptima HPV assay, for the qualitative detectionof E6/E7 viral messenger RNA (mRNA) from 14 high-risk types of humanpapillomavirus (HPV) in cervical specimens. The high-risk HPV types detected bythe assay include: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68.

Methodology

Molecular

Specimen Requirements

Cervical Cells: 2 mL, ThinPrep®or SurePath™

Storage and Transportation

ThinPrep: 105 days (not above 8°C for more than 30 days) SurePath: 21 Days Store at 2°C to 30°C and ship at room temperature.

Turnaround Time

3-4 days

CPT Codes

87624